These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 28189348)

  • 1. [Treatment of macular hematoma complicating AMD by vitrectomy, subretinal r-TPA injection, intravitreal injection of bevacizumab combined with gas tamponade: Report of 4 cases].
    Abboud M; Benzerroug M; Milazzo S
    J Fr Ophtalmol; 2017 Feb; 40(2):133-137. PubMed ID: 28189348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of hematomas in age related macular degeneration by vitrectomy and subretinal injection of r-tPA: Preliminary results (French translation of the article)].
    Boiché M; Angioi-Duprez K; Conart JB; Berrod JP
    J Fr Ophtalmol; 2020 Jan; 43(1):43-50. PubMed ID: 31870667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of hematomas in age related macular degeneration by vitrectomy and subretinal injection of r-tPA: Preliminary results.
    Boiché M; Angioi-Duprez K; Conart JB; Berrod JP
    J Fr Ophtalmol; 2019 Nov; 42(9):e391-e397. PubMed ID: 31471124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of pigment epithelial detachment in AMD with submacular hemorrhage treated with vitrectomy and subretinal co-application of rtPA and anti-VEGF.
    Treumer F; Wienand S; Purtskhvanidze K; Roider J; Hillenkamp J
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1115-1123. PubMed ID: 28280989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pars plana vitrectomy, subretinal injection of recombinant tissue plasminogen activator and fluid-gas exchange in the management of massive submacular hemorrhages secondary to age-related macular degeneration].
    Auriol S; Mahieu L; Lequeux L; Quintyn JC; Pagot-Mathis V
    J Fr Ophtalmol; 2010 Feb; 33(2):84-91. PubMed ID: 20092910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical results of intravitreal administration of tissue-type plasminogen activator (tPA) and gas for removal of subretinal hemorrhage in senile macular degeneration].
    Framme C; Toukhy HE; Sachs HG; Spiegel D; Roider J; Gabel VP; Lohmann CP
    Klin Monbl Augenheilkd; 2000 Jan; 216(1):33-9. PubMed ID: 10702940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pars plana vitrectomy, subretinal injection of tissue plasminogen activator, and fluid-gas exchange for displacement of thick submacular hemorrhage in age-related macular degeneration.
    Haupert CL; McCuen BW; Jaffe GJ; Steuer ER; Cox TA; Toth CA; Fekrat S; Postel EA
    Am J Ophthalmol; 2001 Feb; 131(2):208-15. PubMed ID: 11228297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional and structural outcome after vitrectomy combined with subretinal rtPA Injection with or without additional intravitreal Bevacizumab injection for submacular hemorrhages.
    Rickmann A; Paez LR; Della Volpe Waizel M; Bisorca-Gassendorf L; Schulz A; Vandebroek AC; Szurman P; Januschowski K
    PLoS One; 2021; 16(4):e0250587. PubMed ID: 33930041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration.
    Chang W; Garg SJ; Maturi R; Hsu J; Sivalingam A; Gupta SA; Regillo CD; Ho AC
    Am J Ophthalmol; 2014 Jun; 157(6):1250-7. PubMed ID: 24531021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TISSUE PLASMINOGEN ACTIVATOR FOR SUBFOVEAL HEMORRHAGE DUE TO AGE-RELATED MACULAR DEGENERATION: Comparison of 3 Treatment Modalities.
    Fassbender JM; Sherman MP; Barr CC; Schaal S
    Retina; 2016 Oct; 36(10):1860-5. PubMed ID: 26945238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flattening of retinal pigment epithelial detachments after pneumatic displacement of submacular hemorrhages secondary to age-related macular degeneration.
    Kimura M; Yasukawa T; Shibata Y; Kato A; Hirano Y; Uemura A; Yoshida M; Ogura Y
    Graefes Arch Clin Exp Ophthalmol; 2018 Oct; 256(10):1823-1829. PubMed ID: 29961921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemorrhagic age-related macular degeneration managed with vitrectomy, subretinal injection of tissue plasminogen activator, gas tamponade, and upright positioning.
    Kapran Z; Ozkaya A; Uyar OM
    Ophthalmic Surg Lasers Imaging Retina; 2013; 44(5):471-6. PubMed ID: 24044710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of submacular hemorrhage with intravitreal versus subretinal injection of recombinant tissue plasminogen activator.
    Hillenkamp J; Surguch V; Framme C; Gabel VP; Sachs HG
    Graefes Arch Clin Exp Ophthalmol; 2010 Jan; 248(1):5-11. PubMed ID: 19669780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pneumatic displacement of submacular hemorrhage with or without tissue plasminogen activator.
    Mizutani T; Yasukawa T; Ito Y; Takase A; Hirano Y; Yoshida M; Ogura Y
    Graefes Arch Clin Exp Ophthalmol; 2011 Aug; 249(8):1153-7. PubMed ID: 21445629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of recombinant tissue plasminogen activator and gas versus bevacizumab and gas for subretinal haemorrhage.
    Mayer WJ; Hakim I; Haritoglou C; Gandorfer A; Ulbig M; Kampik A; Wolf A
    Acta Ophthalmol; 2013 May; 91(3):274-8. PubMed ID: 21952010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal Recombinant Tissue Plasminogen Activator and Sulphur Hexafluoride Gas for Submacular Haemorrhage Displacement in Age-Related Macular Degeneration: Looking behind the Blood.
    Maggio E; Peroglio Deiro A; Mete M; Sartore M; Polito A; Prigione G; Guerriero M; Pertile G
    Ophthalmologica; 2020; 243(3):224-235. PubMed ID: 31905361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intravitreal injection of rt-PA and gas in the management of minor submacular haemorrhages secondary to age-related macular degeneration].
    Hattenbach LO; Brieden M; Koch F; Gümbel H
    Klin Monbl Augenheilkd; 2002 Jul; 219(7):512-8. PubMed ID: 12195317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follow-up after surgery for hemorrhagic AMD.
    Garcia D; Mahieu L; Soubrane G; Salmon L; Renouvin A; Pagot-Mathis V; Matonti F; Soler V
    J Fr Ophtalmol; 2016 Oct; 39(8):661-667. PubMed ID: 27658564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subretinal coapplication of recombinant tissue plasminogen activator and bevacizumab for neovascular age-related macular degeneration with submacular haemorrhage.
    Treumer F; Klatt C; Roider J; Hillenkamp J
    Br J Ophthalmol; 2010 Jan; 94(1):48-53. PubMed ID: 19946027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue plasminogen activator-assisted vitrectomy for submacular hemorrhage due to age-related macular degeneration.
    Gok M; Karabaş VL; Aslan MS; Kara Ö; Karaman S; Yenihayat F
    Indian J Ophthalmol; 2017 Jun; 65(6):482-487. PubMed ID: 28643713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.